Alliance Pharma Share Price (APH)
APH Share
APH Share
APH Share
APH Share
APH
APH Share
APH Level 2
APH Live
APH Broker
APH Directors
APH Financial
APH
APH Short
APH
Last checked at -
| Alliance Pharma Share Price | |
|---|---|
| Price | 68.50 |
| Bid | 68.50 |
| Ask | 69.00 |
| Change | 0.00 (0.00%) |
| Volume | 223,512 |
| Open | 68.00 |
| High | 70.20 |
| Low | 68.00 |
| Close | 69.60 |
| Currency | GBX |
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 519m |
| Market Capitalisation | £356m |
| Market Size | 15,000 |
| 52 Week High | 95.60 |
| 52 Week High Date | 30-Aug-2018 |
| 52 Week Low | 59.20 |
| 52 Week Low Date | 16-Jan-2019 |
| # Trades | 0 |
|---|---|
| Vol. Sold | 157,004 |
| Sold Value | £107.55k |
| Vol. Bought | 66,508 |
| Bought Value | £45.56k |
| PE Ratio | 18.564 |
| Earnings | 3.69 |
| Dividend | 1.464 |
| Yield | 2.137% |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 22-Aug-19 | 16:35:21 | 68.50 | 6,778 | Sell* | 68.50 | 69.00 | 4,643 | UT Uncrossing Trade |
| 22-Aug-19 | 16:29:46 | 68.50 | 49 | Sell* | 68.50 | 69.00 | 33.57 | A Automatic Execution |
| 22-Aug-19 | 16:29:43 | 69.00 | 72 | Buy* | 68.50 | 69.00 | 49.68 | A Automatic Execution |
| 22-Aug-19 | 16:29:33 | 68.90 | 998 | Buy* | 68.50 | 68.90 | 687.62 | A Automatic Execution |
| 22-Aug-19 | 16:28:56 | 68.90 | 528 | Buy* | 68.50 | 68.90 | 363.79 | A Automatic Execution |
| 22-Aug-19 | 16:28:55 | 68.50 | 742 | Sell* | 68.50 | 68.90 | 508.27 | A Automatic Execution |
| 22-Aug-19 | 16:28:55 | 68.60 | 925 | Sell* | 68.60 | 68.90 | 634.55 | A Automatic Execution |
| 22-Aug-19 | 16:28:50 | 68.60 | 5 | Sell* | 68.60 | 69.00 | 3.43 | A Automatic Execution |
| 22-Aug-19 | 16:28:50 | 68.60 | 7 | Sell* | 68.60 | 69.00 | 4.80 | A Automatic Execution |
| 22-Aug-19 | 16:27:55 | 69.00 | 416 | Buy* | 68.60 | 69.00 | 287.04 | A Automatic Execution |
| Trade Date | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|
| 22-Jan-19 | Buy | Richard Jones held the position of Independent Non-Executive Director at the time of this trade. Richard Jones | 65.28 | GBX | 15,000 | 15,000 |
| 09-Nov-18 | Sell | John Dawson held the position of Non-Executive Director at the time of this trade. John Dawson | 70.10 | GBX | 1,100,000 | 35,476,402 |
| 14-Feb-17 | Exercise of option | Peter Butterfield held the position of Deputy CEO at the time of this trade. Peter Butterfield | 33.25 | GBX | 90,222 | 28,376 |
| 14-Feb-17 | Sell | Peter Butterfield held the position of Deputy CEO at the time of this trade. Peter Butterfield | 48.75 | GBX | 61,846 | 28,376 |
| 27-Oct-16 | Exercise of option | Peter Butterfield held the position of Deputy CEO at the time of this trade. Peter Butterfield | 47.50 | GBX | 200,000 | 200,000 |
Our expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients
Last checked at